Peer Review History
| Original SubmissionAugust 30, 2023 |
|---|
|
PONE-D-23-27830Prevalence and regional disparities of Undiagnosed Diabetes Mellitus in Bangladesh: Results from the Bangladesh Demographic and Health Survey dataPLOS ONE Dear Dr. Hossain, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Editor comments:
Please submit your revised manuscript by Nov 15 2024 11:59PM If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Sheila Rizzato Stopa, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please include a caption for figure 1. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: No Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for the invitation to review this manuscript, and I sincerely apologize for the delay in submitting my comments. The paper addresses a crucial issue for Bangladesh—undiagnosed diabetes and its risk factors—by analyzing data from the nationally representative 2017 Bangladesh Demographic and Health Survey. While the paper has merits, I have several observations concerning the paper's significance for Bangladesh, sample selection, analysis, and overall writing. Specific comments are provided below: 1. A similar paper utilizing the same data and variables has already been published by Rakibul M. Islam and colleagues in the Diabetes Research and Clinical Practice Journal (https://www.sciencedirect.com/science/article/pii/S0168822722000407 ). Despite the similarities, the authors did not mention this until the end of the last paragraph in the discussion section, making the newly submitted paper seemingly unnecessary. 2. The authors present several instances of misleading information, and the references used are often misleading and incorrect. For example, please check the third sentence of the second paragraph of the introduction section, where the authors reference a meta-analysis conducted by the International Diabetes Federation. However, all three citations supporting this claim are from individual authors affiliated with Bangladeshi institutions, analyzing BDHS survey data. This pattern of misleading citations is prevalent throughout the manuscript, rendering many claims inaccurate. 3. The considered sample for analysis is not entirely correct. The inclusion of respondents with gestational diabetes in their analysis is misleading and illogical. 4. Authors considered body mass index (BMI) as one of the independent variables in the analysis and used the global classification of BMI recommended by WHO in 2004. However, WHO later updated their classification for the Asian population, including Bangladesh. Since then, WHO recommends using this new classification for studying events related to non-communicable diseases, such as diabetes and hypertension. The authors' analysis in this regard lacks precision. Please see the new classification here: https://pubmed.ncbi.nlm.nih.gov/14726171/#:~:text=The%20cut%2Doff%20point%20for,points%20for%20each%20population%20separately. 5. The segmentation of semi-urban data is unclear and not available in the dataset. 6. The merging of wealth quintile and residential regions is questionable, potentially masking the true scenario for certain groups unnecessarily. 7. The section on the outcome variable is not entirely clear, especially concerning how authors used the multinomial regression model. 8. While the use of a multivariate multinomial model is methodologically acceptable, there is evidence that, for clustered data like BDHS, multilevel analysis is recommended for more precise results. Additionally, it's unclear whether the authors considered sample weight in their analysis. These make findings reported by the authors are less precise. 9. The manuscript is poorly written with inadequate critical review and comparison in the introduction and discussion sections, respectively. Although I am aware of the PLoS ONE criteria regarding repetition and novelty not being grounds for rejection, considering the need for this paper and other issues, I recommend not accepting it for publication. Reviewer #2: Dear authors, Congratulalions for your work! I consider this to be a high-quality study that uses secondary data from a nationally representative population survey—the Bangladesh Demographic and Health Survey (BDHS)—which evaluated more than 10,000 adults. The research complies with ethical standards and research integrity, and the article adheres to appropriate reporting requirements for data availability. This is original research, and the experiments and statistical analyses appear to have been conducted to a high technical standard. However, as this is a secondary analysis, I find some of the methodological details from the primary survey to be lacking, or at least a reference where such details can be found. The results from Bangladesh are consistent with findings from other regions, so it is crucial for the authors to highlight what unique contributions this study makes to the understanding of diabetes epidemiology. Please see my comments below. Abstract There are two abstracts on the submission. On conclusion, its stated that the groups with elevated risk for diabetes face higher complications without timely detection and treatment. However, I think it´s important to rewrite the sentence to avoid misunderstanding, as the study did not measure the complications. Introduction On the 4th paragraph of introduction, you should give a better link between the ideas of hypertension, smoke and sleep. I could not understand why state about sleep directly after citing the hypertension. Please review. Methods Considering a nationally representative sample, I think it’s important to describe in details the sample selection process; for example, how the participant was selected in each household? It was only one individual for each household, or all residents? The sample included all age groups? I have doubts about these aspects, as you cited exclusion of individuals below 18 years of age. It would be good to have a guide to see the Figure 1. The definition of diabetes and undiagnosed diabetes is crucial to this study, as they represent the primary outcomes. Some bias may be introduced when relying on self-reports or prescription data, as these do not necessarily reflect the patient's actual condition. For example, a person may be prescribed diabetes medication but may not adhere to the treatment. It is important to clarify how glycemic levels were measured and to consider these factors as limitations of the study. Given that the study aims to evaluate regional factors influencing undiagnosed diabetes, I recommend including a detailed description of regional differences, socioeconomic levels, and distinctions between rural and urban areas—perhaps incorporating a map—to enhance the understanding of the results. On methods (Independent variables), the authors cite that “The residential region of the country is classified based on its administrative divisions” and that was categorized as coastal, central, North, or east region. However, on Table 1, the results are presented as “city”, “semi-urban” or “rural”. Please match the information appropriately. For wealth status, which parameters were used to classify as poor, middle and rich? Please explain. Data Analysis: which weights were applied on BDHS. Please describe or cite a reference. Results On table 1, on age group, please put the category <30 first. Why the reference category is 30-39 years old? On “The participants' average age was 39”, it´s important to present the standard-deviation with the average age Discussion The discussion section could be improved, exploring the main risk factors related to undiagnosed diabetes, as the main result of the study. Explaining the structure of the health services could aid in analyzing the prevalence of diabetes in this population, as well as regional differences within the country. Is the prevalence of undiagnosed diabetes considered high? In addition to comparisons with other countries in the region, the authors could discuss the findings in relation to countries with similar public health service structures. In the sentence “The study also noted that individuals with primary and secondary education displayed lower awareness and knowledge about diabetes treatment, contributing to a significant link between education and undiagnosed diabetes”, could this low awareness occur for diabetes diagnosis? As so, part of undiagnosed diabetes could be a case of reporting bias? The person could have been diagnosed previously, but not report it appropriately? If you think so, please include it in the text. In the sentence “This might be due to their ability to consume more glucose, leading to sedentary lifestyles that can contribute to diabetes development”, is there any other explanation? Are the access to health care, glycemic measures, and the diagnosis of diabetes universally distributed in the country? Please explain. When interpreting the relationship between diabetes and nutritional status, the mechanisms underlying these connections should be more thoroughly explored to aid the readers' understanding. For instance, how do increased technology use and prolonged TV watching influence this relationship, and why is the central region of Bangladesh an example? This part seems unclear to me. In the limitations section, the authors mention that 'medication history was not included,' yet in the methods, it is stated that those who 'took prescribed medicine' were considered as having diabetes. Does the medication history referenced in the limitations refer to medications other than anti-diabetic drugs? Please clarify. In the conclusion, when stating that “Overall, the insights gained from this study hold the potential to guide the formulation of targeted interventions aimed at curbing the incidence of undiagnosed diabetes in Bangladesh”, I recommend replace ´incidence´ with ´prevalence´, as the study does not address incidence; Instead, the prevalence of undiagnosed diabetes could be reduced through improved screening. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: No Reviewer #2: Yes: Betine Pinto Moehlecke Iser ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-23-27830R1Prevalence and regional disparities of Undiagnosed Diabetes Mellitus in Bangladesh: Results from the Bangladesh Demographic and Health Survey dataPLOS ONE Dear Dr. Hossain, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Academic Editor's Comments: I have thoroughly reviewed your manuscript in conjunction with the detailed feedback provided by two experienced reviewers. After careful consideration, I share their concerns regarding several key aspects of your work. Based on their constructive recommendations, I invite you to revise and resubmit your manuscript for further evaluation. To strengthen your paper, it is essential that you address the specific issues and suggestions highlighted by the reviewers. I look forward to receiving your revised version and seeing how you've incorporated their valuable insights. Please submit your revised manuscript by Mar 02 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, Md Mohsan Khudri, Ph.D. Academic Editor PLOS ONE [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #3: (No Response) Reviewer #4: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #3: Partly Reviewer #4: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #3: Yes Reviewer #4: No ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #3: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #3: Yes Reviewer #4: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #3: Unfortunately, I did not participate in the first round of evaluations, so my observations were not incorporated until this second round, which should contain specific aspects and not be as generic as the following: Consideration 1: The RR is usually defined as the incidence rate of the outcome in the treatment or exposed group divided by the incidence rate of the outcome in the control or non-exposed group. The RRR is defined as a risk reduction. These indicators or effect measures are used in longitudinal studies, not in cross-sectional studies. Consideration 2: In logistic regression (binomial or multinomial), the coefficients of the logit (β), if they are exponents (expβ), are interpreted as ORs. These ORs are used to measure the association between risk factors and the prevalence of a condition. Although ORs are not exactly the same as prevalence ratios (PRs), they can be interpreted in a similar way to understand the relationship between variables. For these reasons, it is preferable to use OR rather than RRR. On other hand, ORs in a prevalence study do not allow the following to be said: “Education played a significant role: individuals with primary and secondary education had 52% (RRR = 1.52, 95% CI = 1.07-2.15) and 63% (RRR = 1.63, 95% CI = 1.12-2.38) higher risk of undiagnosed diabetes, respectively, compared to those with no formal education”. However, the following paragraphs are more appropriate: • Education played a significant role: individuals with primary and secondary education had 52% (OR = 1.52, 95% CI = 1.07-2.15) and 63% (OR = 1.63, 95% CI = 1.12-2.38) increased odds of having undiagnosed diabetes, respectively, compared to those with no formal education. • The odds of having undiagnosed diabetes were 1.5 times (OR = 1.52, 95% CI = 1.07-2.15) and 1.6 times (OR = 1.63, 95% CI = 1.12-2.38) higher for those with primary and secondary education, respectively, compared with those with no formal education. • Education played a significant role: individuals with primary and secondary education had 52% (OR = 1.52, 95% CI = 1.07-2.15) and 63% (OR = 1.63, 95% CI = 1.12-2.38) higher prevalence of undiagnosed diabetes, respectively, compared to those with no formal education. Other paragraphs need to be improved: “We found hypertension is strongly associated with an increased risk of both diagnosed and undiagnosed diabetes” This is because the study did not have a follow-up period, and it is not possible to calculate incidence (risk) rates. The following paragraph is more appropriate: “We found hypertension is strongly associated with both diagnosed and undiagnosed diabetes” It is recommended that authors read the following document in order to use the terms correctly: Hsueh, L., Wu, W., Hirsh, A. T., de Groot, M., Mather, K. J., & Stewart, J. C. Undiagnosed diabetes among immigrant and racial/ethnic minority adults in the United States: National Health and Nutrition Examination Survey 2011-2018. Annals of Epidemiology 2020, 51: 14–19. https://doi.org/10.1016/j.annepidem.2020.07.009 Additionally, other limitations must be included. Firstly, glucose levels were measured using capillary blood, and although a conversion to plasma glucose was performed, this method may still introduce some inaccuracies. Second, a single blood glucose measurement is not sufficient to diagnose diabetes. It is possible that some people diagnosed with diabetes may not have the condition on a second measurement of fasting plasma glucose (false positive) and, conversely, some people who do have diabetes may be missed (false negative). Reviewer #4: While the manuscript addresses a critical and important topic, it requires substantial revisions before it can be considered for publication. My major comments are outlined below: Methods: • Compared to the standard multinomial logistic regression model, multilevel multinomial logistic regression analysis offers significant advantages. It reduces parameter overestimation and provides more accurate estimates, particularly in hierarchical data structures like the DHS survey. The authors are encouraged to consider this approach or discuss why they opted for the current method. • To assess the stability of a multinomial logistic regression model applied to cross-sectional data, various methods focusing on model assumptions, goodness-of-fit, and predictive performance across data subsets can be employed. This assessment is missing in the manuscript. Additionally, the results of multicollinearity checks were not reported. Addressing these aspects would strengthen the validity of the findings. • The adequacy of the sample size for a stable multinomial logistic regression model is a critical consideration, especially given the number of predictor variable categories. Adhering to the events per predictor parameter (EPP) rule ensures the statistical soundness and reliability of the findings. Harrell (2001, DOI: 10.1007/978-3-319-19425-7) suggests at least 15 EPP, and others recommend at least 20 EPP (e.g., Ogundimu et al., 2016, DOI: 10.1016/j.jclinepi.2016.02.031; Austin & Steyerberg, 2014, DOI: 10.1177/0962280214558972). Based on Table 1, adhering to the 15 EPP rule requires at least 345 events, but the smallest outcome category (i.e., undiagnosed diabetes) has only 304 events. This should be discussed in the limitations section. • The peer reviewer’s comment on this was not addressed in the revision. The statement, ‘We classified the wealth status as a household-level element as Poor, Middle, and Rich groups,” lacks clarity. Was this classification based on a specific reference or methodology? If so, please provide the source. If it was developed independently, additional justification and details are needed. • It is unclear whether a specific framework or rationale was followed for selecting predictors in the model. Did the authors rely on theoretical considerations, empirical evidence, or data-driven approaches (e.g., stepwise selection)? If so, please state this clearly and justify the choices made. Providing transparency here would enhance the study’s methodological rigor. Discussion • The manuscript’s discussion section restates key findings and compares them to studies in agreement but offers limited mechanistic explanations for the observed patterns. Providing insights into the underlying biological, behavioral, or systemic factors contributing to these patterns would enhance the discussion. • The manuscript highlights regional differences but does not explore the underlying causes of these disparities in depth. Evidence suggests that people living in coastal areas may experience a higher prevalence of diabetes than those in inland regions due to a combination of lifestyle, dietary habits, and environmental factors (DOI: 10.1136/bmjdrc-2015-000110; 10.1186/1471-2458-13-299; 10.15226/2374-6890/4/3/00181), which is not in line with the study findings. Expanding on these aspects would better align the discussion with the title’s focus. • Overall, the whole discussion section requires a thorough review. Some examples: a) The statement, "Interestingly, individuals with college education exhibit a lower risk for diagnosed diabetes but a higher risk for undiagnosed diabetes," should be revised because the RRRs for diagnosed diabetes are not statistically significant. b) Similarly, for undiagnosed diabetes, terms like “greater” should not be used when the 95% confidence intervals for overweight and obese categories overlap. c) The claim, “The analysis reveals a difference in diabetes prevalence based on residence type,” should be clarified or revised. While regional differences are evident, no significant differences by residence type (urban, rural, semi-urban) were found. d) To explore region/community-level factors, incorporating data from the community questionnaire, such as the distance to healthcare facilities, could provide valuable insights into regional disparities. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #3: No Reviewer #4: Yes: Karar Zunaid Ahsan ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Prevalence and regional disparities of Undiagnosed Diabetes Mellitus in Bangladesh: Results from the Bangladesh Demographic and Health Survey data PONE-D-23-27830R2 Dear Dr. Hossain, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Md Mohsan Khudri, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #3: All comments have been addressed Reviewer #4: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #3: Yes Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #3: Yes Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #3: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #3: Yes Reviewer #4: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #3: The authors have adequately responded to all the issues raised. They have provided bibliography that clarifies the points raised in my previous report. Reviewer #4: I thank the authors for thoughtfully incorporating my peer review comments into their manuscript. I believe the revisions have strengthened the clarity and impact of the manuscript. For the authors' information, the statement that "... the dataset does not include information on the distance to healthcare facilities" is not correct. The distance to health facility data are indeed available in the DHS community questionnaire, which can be linked with the DHS individual recode data (at the cluster level) if required. Again, I appreciate the authors' careful attention to the feedback and commend their efforts to improve the manuscript. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #3: No Reviewer #4: Yes: Karar Zunaid Ahsan, PhD ********** |
| Formally Accepted |
|
PONE-D-23-27830R2 PLOS ONE Dear Dr. Hossain, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Md Mohsan Khudri Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .